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Complementary medicine is a formal method of health care in most countries of the ancient
world. It is expected to become more widely integrated into the modern medical system,
including the medical curriculum. Despite the perception of modern medicine as more effica-
cious, traditional medicine continues to be practiced. More than 70% of the developing world’s
population still depends primarily on the complementary and alternative systems of medicine
(CAM). In rural areas, cultural beliefs and practices often lead to self-care, home remedies or
consultation with traditional healers. Herbal medicine can be broadly classified into four basic
systems as follows: Traditional Chinese Herbalism, Ayurvedic Herbalism, Western Herbalism—
which originally came from Greece and Rome to Europe and then spread to North and South
America and Traditional Arabic and Islamic Medicine (TAIM). There is no doubt that today
the concept of Arabic traditional herbal medicine is a part of modern life in the Middle East,
and it is acquiring worldwide respect, with growing interest among traditional herbalists
and the scientific community. TAIM therapies have shown remarkable success in healing acute
as well as chronic diseases and have been utilized by people in most countries of the
Mediterranean who have faith in spiritual healers. TAIM is the first choice for many in dealing
with ailments such as infertility, epilepsy, psychosomatic troubles and depression. In parallel,
issues of efficacy and safety of complementary medicine have become increasingly important
and supervision of the techniques and procedures used is required for commercial as well as
traditional uses. More research is therefore needed to understand this type of medicine and
ensure its safe usage. The present review will discuss the status of traditional Arab medicine
(particularly herbal medicine), including the efficacy and toxicity of specific medicinal prepara-
tions, with an emphasis on the modern in vitro and in vivo techniques.
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Traditional Arabic and Islamic Medicine Joins
TCM, CAM, Kampo and Ayurveda
There are several well-known and established medicinal
plant heritages worldwide including the Kampo, TCM,
TIM and Ayurveda. There has been increased global
interest in traditional medicine and there are efforts
underway to monitor and regulate herbal drugs and tradi-
tional medicine. China has been successful in promot-
ing its therapies with more research and a science-based
approach, while Ayurveda still needs more extensive
scientific research and evidence bases. Kampo medicine
is widely practiced in Japan, where it is fully integrated
into the modern health care system. Kampo is based
on traditional Chinese medicine but adapted to Japanese
culture. With only slight modifications, it has been
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properly cited.adopted also in Taiwan and exported from Taiwan to the
West. Kampo spread rapidly during the period 1985–95;
after that, the number of practitioners stabilized at a near-
constant level (1,2). By 1985, it was reported that about
20–25% of the medical doctors in Japan were prescribing
some herbal medicines in their practice. However, as
pointed out by Terasawa Katsutoshi, only about 100 or so
doctors were routinely prescribing Kampo medicines
to their patients. The proportion of doctors that provide
some Kampo medicines has risen to about 50% or more
by some estimates, with a proportional increase in Kampo
specialists by more than 200. In addition, there are
about 10000 pharmacies in Japan that dispense herbal
formulas. In Japan, unlike Western countries, some part
of Kampo remedies and acupuncture are covered by
public health insurance (1,2). Therefore, Japanese practi-
tioners of Kampo and acupuncture would object to their
inclusion in Complementary and Alternative Medicine
(CAM) and would rather regard themselves as belonging
to the authentic traditional medicine. Ayurveda, tradi-
tional Indian medicine (TIM) and traditional Chinese
medicine (TCM) remain the most ancient yet living
traditions.
The history and development of TCM in Taiwan
started during the end of the Ming dynasty when large-
scale migration from Mainland China took place (3). The
migrants brought with them a 2000 year old knowledge
of TCM, complemented by the rich flora and fauna
of Taiwan and the local knowledge of the aboriginal
people. TCM has now become the highest priority in the
Taiwan’s blueprint for the development of biotechnology.
With thousands of years of accumulated knowledge and
experience in herbal medicine, there is a will to preserve
it at any cost, although in early communist China it was
discouraged. A utilization pattern for herbal medicine is
just emerging in Taiwan. Uninformed patients, unscru-
pulous traders, adulterated preparations, unlicensed prac-
titioners and illegal sources for herbal medicines have
been blamed for creating a bad image of herbal medi-
cine use in Taiwan (4,5). The decision to cover Chinese
Herbal Medicine (CHM) treatment under Taiwan’s
National Health Insurance (NHI) in 1992 had a big
impact on the pattern of CHM unitization in Taiwan.
Some researchers tried to find some link between the
TCM and Ayurveda from the Indian subcontinent and
their integration with other systems of medicine, includ-
ing Western medicine, to realize the concept of sustain-
able medicine (6). In this aspect, several herbal medicines
for potential steroidogenic activity have been screened
both in vivo and in vitro to analyze their effect on steroid
hormones.
Traditional Chinese herbal therapy can be characterized
by the use of a large number of multi-herb formulae.
To provide modern and Western scientists who do not
possess background knowledge of Chinese literature and
culture easy access to information, a database with more
than 11000 traditional Chinese herbal formulae was
constructed (6). All information was then translated into
understandable scientific terms in English. Traditional
Arabic and Islamic Medicine Joins (TAIM), on the other
hand, is based on single plant species or a mixture of
a small number of local plant species.
According to Olalde Rangel et al. (7), recent past
and current naturalists and phytotherapeutic practitioners
share a long and impressive tradition of knowledge and
pride in curing illnesses. These qualities have been sub-
stantiated by the success of Chinese, Kampo, Ayurvedic,
Chumash or Mayan among many other traditional
medicines. From these traditional medicines it has been
demonstrated that every culture is capable of under-
standing and ‘inventing’ the meaning of disease and
finding probable cures (7). They may even be different
from our modern medical views. The variety and extent
of cultures to provide answers to traditional medicines
and to unsolved pathologies are firmly grounded in
the curiosity and observational capabilities of humans.
To ensure this culture, there are collective factors,
‘a background of extensive family practice in traditional
medicine’ crucial in the transmission and survival of
medicinal plant knowledge among ethnic groups. How-
ever, there is a possible curtailment of the wisdom and
therapies of traditional medicines that comes with geo-
graphical and ethnic boundaries. In addition, the number
of plants, potential formulations or properties is a for-
midable concern for individual caregivers or groups to
understand, store and transmit (7).
TAIM started hundreds of years ago and were used
until recently in many of the primary books in libraries
throughout Europe. Research into the TAIM herbs has
been conducted in many Arab countries such as Syria,
Morocco, Yemen, Egypt and others. The most recent
surveys conducted on the potential uses of plant species
in the Mediterranean region by ethnopharmacologists
recorded 250–290 plant species belonging to different
families still in use (8,9). The remedies are administered
by practitioners in forms of standard decoction prepared
by boiling plant parts in hot water, infusion in water or
oil or inhalation of essential oils. It is also taken as juice,
syrup, roasted material, fresh salad or fruit, macerated
plant parts, oil, milky sap, poultice and paste. In recent
years, remedies based on TAIM herbs have been tested in
cooperation with physicians and started to be routinely
prescribed in Europe and in Mediterranean countries to
their patients.
According to the World Health Organization (WHO),
more than three-quarters of the world’s population
rely upon traditional medicine, mainly herbs (medicinal
plants), for health care. Phytotherapy existed in one
way or another in different cultures/civilizations, but
the systematic and comprehensive works of Ibn Sina
(Avicena in the West) in the form of Al-Qanun-fil-Tib
(Canon of Medicine) occupies an eminent place in the
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over 600 years. During the 15th and 16th centuries alone
it was published more than 35 times. In addition to the
use of plants in their crude form for health care, they
have been the main source for chemical drugs. Today
there is a revival of interest in the use of medicinal plants
in the form of standardized extracts/botanicals partly
due to the high cost involved in the development of
patentable chemical drugs and their multiple side effects.
Botanicals such as Ispaghol, Garlic, Ginseng, Ginger,
Ginkgo, St John’s Wort, Mucuna prureins and Saw
palmetto are gaining popularity for the purpose of health
care. The impact of journals publishing data on medicinal
plants is increasing and there is a rising trend to include
phytotherapy in the curriculum of medical schools in
North America and Europe. Over 70% of German
physicians prescribe herbs, and St. John’s Wort is more
commonly used than any chemical medicine to treat mild
to moderate depression. Phytotherapy is considered
relatively safe as it contains multiple chemicals with a
specific composition acting as ‘effect-enhancing and/or
side-effects neutralizing’, though there is limited scientific
evidence for this assumption. Multidisciplinary team
work including ethnobotanists, pharmacologists, physi-
cians and phytochemists is essential for the fruitful out-
come of medicinal plants research, and such international
symposia as the aforementioned conference help to
achieve this goal.
Revival and Preservation of TAIM Knowledge
Parallel to the increasing interest in ‘modern’ CAM
therapies and the historical importance of TAIM, there is
a similar trend in research activities dealing with the
efficacy and safety of medicinal plants in the Middle
East. Historical and current studies indicate that the
Eastern region of the Mediterranean has been distin-
guished for long periods with a rich inventory of natural
medicinal herbs. It is well documented that TAIM has
contributed greatly to the development of modern medi-
cine in Europe and remains one of the closest forms of
original European medicine. In recent years researchers at
the Galilee Society Research and Development Center,
in cooperation with different institutes, have published
more than 20 articles and review papers in peer reviewed
Journals on this subject (8–16). These articles demon-
strate the importance of traditional Arabic medicine and
indicate that the Eastern region of the Mediterranean has
been distinguished from other regions by a rich inventory
of complementary alternative medicine, in particular
herbal medicine. The data collected during these studies
indicated that 200–250 herbs are still used in treating
human diseases and are sold or traded in market places
in the Mediterranean region or internationally. Some of
these plant species have been investigated and bioactive
ingredients extracted to treat various human diseases and
as botanical pesticides (17–20).
The modern use of Arab botanical medicines has
historical roots in ancient Arabic medicine. Arab herbal-
ists, pharmacologists, chemists and physicians in the
middle ages adopted the ancient medicinal practices of
Mesopotamia, Greece, Rome, Persia and India. Medical
innovations introduced by Arab physicians included:
the discovery of the immune system, the introduction of
microbiological science and the separation of medicine
from pharmacological science. Recent ethnopharmaco-
logical surveys conducted by different groups in the
Middle East support the necessity of proper handling of
herbal medicine used in TAIM which requires suitable
regulation and licensing in order to ensure supply of
appropriate and safe products (8,9). Fortunately, today
there is a countertrend underway to preserve natural
botanical resources through an increasing emphasis on
conservation by way of botanical gardens, greenhouses,
herbariums, tissue cultures, propagation and seed banks.
In an effort to help revive and preserve the knowledge
of TAIM, an international conference on the current
state of research and practice in the field was organized
in 2007. This three-day conference took place in Amman,
Jordan during August 8–10, and included an exhibition
and poster session. The conference intended to: (i) estab-
lish an institution to serve as a network for all stake-
holders in TAIM, as a prerequisite to revitalizing this
important subject and to coordinate research and
different activities in this field; (ii) revive the heritage of
TAIM in order to present it in its normal environment,
in order to release it from the political restrictions of the
Middle East, (iii) revitalize this heritage as a scientific
discipline and raise awareness of TAIM; (iv) explore the
economic and sustainability aspects of this heritage and
encourage investment to develop pharmaceutical prod-
ucts based on this culture and (v) increase the number
of practitioners and quality of the practice of TAIM
by training new and existing practitioners (21). The con-
ference was designed for research scientists, local and
regional traditional healers, international pharmaceutical
and medical research companies, medical doctors, ethno-
pharmacologists and other parties interested in the study
of traditional Arabic and Islamic medicine. All bodies
and institutions, research centers and interested parties
working in the field of Arab medicinal plants were invited
to participate in the conference, which was structured
into six sessions. Discussions touched on the historical
and cultural aspects of Arabic Islamic medicine and its
contribution to modern medicine and to human well-
being. The global scientific research on medicinal and
aromatic plants, pharmaceutical research, clinical trials,
as well as international legislation and intellectual prop-
erty rights on Arabic and Islamic medicinal plants of
the region were also reviewed. Each of the six sections
eCAM 2010;7(4) 421discussed a different issue related to TAIM. Their main
points are delineated as described subsequently.
Ethnopharmacology of Medicinal Plants used in TAIM
Historical and current studies indicate that the Eastern
region of the Mediterranean has been distinguished from
other regions by a rich inventory of CAM, in particular
herbal medicine. Data also indicate that there is a flour-
ishing and well-developed trade of herbs, some of which
are rare or endangered species. Unfortunately, with
regard to the status of the herbalists’ knowledge, herbal
medicine in our region is mostly prescribed symptom-
atically by ethnopharmacologists; that is, based on signs
and symptoms alone, rather than on a full understand-
ing of the underlying disease. In other cases, herbs used
today may not even correspond to the plants described
originally in the old literature, as the former are culti-
vated from herbs that went through different breeding
procedures over several centuries (10).
TAIM Heritage
During the 8th until the 11th centuries, Arab physicians
upgraded the existing knowledge about herbs and their
potential medical efficacy and safety. Their greatest con-
tributions to modern medicine were the immune system
and introduction of microbiological science [(22), for
more details, see review in Ref. (12)]. The Eastern region
of the Mediterranean has been distinguished throughout
generations by a rich inventory of natural medicinal
herbs (8,22–24). The Middle Eastern region was covered
with >2600 plant species of which >700 were noted
for their use as medicinal herbs or botanical pesticides.
Unfortunately, recent ethnopharmacological surveys
reveal that 200–250 plant species are still in use in Arab
traditional medicine for the treatment of various diseases
(8,25–28). There are several factors endangering plant
diversity or even causing eradication of these herbs,
including habitat loss, habitat degradation and over-
harvesting (29). Recent ethnopharmacological surveys
conducted by different groups in the Middle East support
the necessity of proper handling of herbal medicine which
requires suitable regulation and licensing in order to
ensure supply of suitable and safe products (13,25).
Medicinal plants in the Middle Eastern region and
worldwide are becoming increasingly rare due to the
ongoing destruction of their natural habitat and detri-
mental climatic and environmental changes. As a result,
it is predicted that in semi-arid regions such as the
Middle East, a number of species will disappear within
the next 10 years, particularly in desert or dry areas.
This gives an added sense of urgency to initiate preserva-
tion programs of regional medicinal plant genetic
resources (15).
Al-Maissam
Al-Maissam, the Galilee Society’s Medicinal Plants
Center, was established based on in-depth study of
TAIM and intended to provide an efficient model
for preserving and developing traditional knowledge on
Arabic medicinal plants. A comprehensive survey of
traditional Palestinian herbal medicine practitioners was
conducted in order to assess the current status of the
herbal medicinal practice (8,10). Results demonstrated
that, unfortunately, most practitioners have very limited
knowledge about herbal medicine and younger practi-
tioners had even poorer knowledge than their older
counterparts, while many practitioners are turning to
‘mystical’ or ‘magical’ methods of healing. In addition,
plants used in certain regions are not used in others, the
education level of practitioners is in decline, some medic-
inal plant species are endangered and plant mixtures are
of poorer quality and less variety in comparison to the
past (8,10). As a result of this survey, it became clear that
indigenous plant knowledge is disappearing across recent
generations. The conclusion to be drawn was clear—that
traditional Palestinian medicinal practice is suffering and
that in time, if action is not taken to ensure its survival,
important parts of this heritage may disappear com-
pletely and a wide variety of methods of treating various
diseases may be lost to humanity. The first effort made
by the Galilee Society to revive the Palestinian traditional
medicinal heritage was the establishment of Al-Maissam.
Al-Maissam, the Galilee Society’s Medicinal Plants
Center, was founded in 1999 with main objectives of
preserving and rediscovering the ancient Arab legacy of
herbal medicine. Its activities include preserving native
medicinal plants, preserving and advancing ethnobotany
of the native flora, and spreading this knowledge to all
levels of society (especially among the younger genera-
tion). It is a unique biotechnology center and the first in
our region where modern advanced research is used with
traditional Arab herbal medicine, rendering it compatible
with modern phytotherapy.
In vitro Studies
In general, in vitro test systems represent the first phase
of the evaluation procedure. The in vitro cell culture
methods have the advantage of relatively well-controlled
variables and are generally accepted as a very effective
method for safety testing. Advantages of these systems
over classical methods (such as long term studies on
experimental animals) include relatively well-controlled
variables, decreased costs, a reduced time to completion,
and reduced numbers of animals necessary to complete
the study. The fact that cells and tissues in vivo do not
exist in isolation but communicate with and are inter-
dependent of neighboring tissue makes it essential to
simulate the in vivo situation (13,14).
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the conference, (21) including anti-colon-cancer effects
of Thymoquinone, a natural drug with pro-oxidant
activities. Also, promising data was shown about
Salograviolide A isolated from the indigenous Lebanese
plant Centaurea ainetensis. Salograviolide A causes
growth inhibition and cell death in skin cancer cells.
In vivo and Clinical Trials
The use of in vivo experimentation and clinical trials
are important methods, and despite the limitations of
animal experimentation, they are still crucial in herbal
drug development. Developing a therapeutic remedy from
herbal origins is a complex process that has to pass
through various important preclinical steps. These steps
include standardization of the herbal extract, providing
evidence of pharmacological activity, and providing
evidence of safety.
Pharmacological screening has to be carried out ulti-
mately on laboratory animals and this has many ethical
considerations regarding the proper conduct of such
screening and the expected value of its outcomes. The use
of laboratory animals is unavoidable but should be
rationalized through careful planning. Preliminary in vitro
testing should give some idea of the possible mechanisms
of action and potential therapeutic usefulness of an
herbal extract, but obviously has its shortcomings. Such
tests provide no information regarding biotransformation
of the extract in the body, pharmacokinetic aspects of
absorption and fate. To determine potential therapeutic
usefulness in a certain disease state, however, appropri-
ate animal models have been developed that mimic the
human condition to some extent. Animal models have
been developed for many conditions, including hyperten-
sion, myocardial infarction, atherosclerosis, ischemia,
bronchial asthma, arthritis, diabetes, Parkinsonism,
depression, epilepsy, gastric ulcers, reflux oesophagitis,
inflammatory bowel disease, cancer, etc. Extrapolation of
results from animal to human should be carried out with
great caution. Animal models only mimic the symptoms
in humans, but not the etiology or the overall clinical
picture. Thus, it is not possible to say that an extract,
which lowers blood pressure in rats rendered hypertensive
by L-NAME, where the hypertension is due to endothe-
lial dysfunction, would function as well in a patient
whose hypertension is due to any other cause. Strepto-
zotocin induced diabetes in rat is not exactly the same as
diabetes in humans: not only is the condition different in
etiology, but the human response may be quite different
from that of the rat, particularly since diabetes in humans
is normally associated with a number of events that may
not be seen in the rat.
The metabolism and pharmacokinetic behavior of
active constituents may differ from species to species,
and accordingly the interpretation of animal findings may
not necessarily be applicable to humans. In general,
therefore, animal models are artificially induced condi-
tions said to be analogous to the human diseases they are
intended to simulate, but they differ substantially from
their human ‘counterparts’ in both cause and clinical
course. This also holds true for toxicological studies.
Such studies should always be performed according to
international guidelines and are a prerequisite for eval-
uating the safety of potentially useful therapeutic agents.
Market Authorization Regulations for Herbal Products
Regulations are needed to ensure safety, quality and effi-
cacy of herbal medicines. Countries define herbal medic-
ines differently and have adopted various approaches to
licensing, dispensing, manufacturing and trading these
products. The main differences in the regulations govern-
ing herbal medicines in different countries were discussed
at the conference. Within Europe, and according to the
country using them, herbal medicines are either fully
licensed as medicines with efficacy proven by clinical
trials, or have a more simplified approach toward proof
of efficacy. In the USA, most herbal products are
considered dietary supplements and thus are not required
to meet the more stringent standards for drugs specified
in the Federal Food, Drugs and Cosmetic Act. These
different approaches have resulted in differences in the
availability of some herbal medicines.
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